33 results
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
executives to focus on long term performance and promote retention and rewards based on company and individual performance. The compensation policies … in companies of the Peer Group;
whether and to what extent granting additional stock options will serve as a reasonable “retention incentive” to the applicable
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
could adversely affect the Company’s retention of suppliers.
The Arrangement is dependent upon satisfaction of various conditions, and as a result … ) grant, provide or amend the terms of any change-of-control, retention, severance or termination compensation or benefits to any Company Associate; or (E
6-K
EX-99.2
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
compensation, salary continuation, change-in-control, retention, severance, termination, garden leave, pay in lieu, gross-up, pension, profit-sharing … of any asset) and any conditional sales agreement, title retention agreement or lease in the nature thereof.
“End Date” has the meaning set forth
6-K
EX-99.2
BLU
Bellus Health Inc
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
options) to encourage executives to focus on long term performance and promote retention and rewards based on company and individual performance … positions in companies of the Peer Group;
whether and to what extent granting additional stock options will serve as a reasonable “retention incentive
6-K
EX-99.1
BLU
Bellus Health Inc
14 Nov 22
Open Market Sale Agreementsm
5:19pm
the Securities Act including timely filing with the Commission or retention where required and legending, and each such Free Writing Prospectus, as of its
6-K
EX-99.2
qj9 5z3czk6
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
6-K
EX-99.2
4uz5on0mjuqbmfr40cu2
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
40-F
EX-99.1
9gv3ud
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.2
0a79ag
15 Dec 21
BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States
5:15pm
6-K
EX-99.2
un9mv0ekkuspjb18
9 Apr 21
Notice of Annual Meeting of Shareholders
12:00am
40-F
EX-99.1
xbr w8sfr
25 Feb 21
Annual report (Canada)
4:58pm
6-K
EX-99.1
aat562aj534trq gfcz4
23 Dec 20
Open Market Sale Agreementsm
5:06pm
6-K
EX-99.1
53csn72pmp5n10gy
20 Oct 20
As Representatives of the several Underwriters
4:43pm
6-K
EX-99.2
ivr mosx4cvtium4y
8 Apr 20
Notice of Annual and Special Meeting of Shareholders
9:41am
40-F
EX-99.1
r6gd5rem r1w3738r
27 Feb 20
Annual report (Canada)
5:13pm
F-10
EX-4.4
ofu29 fx6tvf30c
20 Dec 19
Registration of securities (Canada)
4:03pm
F-10
EX-4.1
g0slhwezm u2l5r2
20 Dec 19
Registration of securities (Canada)
4:03pm
F-10/A
EX-3.1
g7rgn4ufow7brzdwyncf
4 Sep 19
Registration of securities (Canada) (amended)
4:44pm
F-10
EX-4.4
sx40ixx5
3 Sep 19
Registration of securities (Canada)
7:53am
F-10
EX-4.1
hmmqg3hb
3 Sep 19
Registration of securities (Canada)
7:53am